Dymon Asia Capital Singapore PTE. LTD. Buys 21,671 Shares of Cognex Corporation $CGNX

Posted by Brenda Bartman on Jun 14th, 2026

Dymon Asia Capital Singapore PTE. LTD. lifted its stake in Cognex Corporation (NASDAQ:CGNX – Free Report) by 75.1% during the fourth quarter, Holdings Channel reports. The fund owned 50,527 shares of the scientific and technical instruments company’s stock after acquiring an additional 21,671 shares during the quarter. Dymon Asia Capital Singapore PTE. LTD.’s holdings in Cognex were worth $1,818,000 as of its most recent filing with the SEC.

Several other institutional investors also recently added to or reduced their stakes in CGNX. Northwestern Mutual Wealth Management Co. increased its position in Cognex by 173,138.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock worth $376,979,000 after buying an additional 10,471,400 shares during the period. Norges Bank bought a new position in Cognex in the 4th quarter worth approximately $73,103,000. Alyeska Investment Group L.P. bought a new position in Cognex in the 4th quarter worth approximately $68,388,000. AQR Capital Management LLC increased its position in Cognex by 18,810.9% in the 2nd quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock worth $56,657,000 after buying an additional 1,785,159 shares during the period. Finally, Pictet Asset Management Holding SA increased its position in Cognex by 27.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock worth $252,360,000 after buying an additional 1,529,010 shares during the period. 88.12% of the stock is owned by institutional investors.

Cognex Trading Up 2.4%

Shares of NASDAQ:CGNX opened at $63.61 on Friday. Cognex Corporation has a 1-year low of $29.22 and a 1-year high of $71.90. The firm has a market capitalization of $10.59 billion, a PE ratio of 75.73 and a beta of 1.52. The business’s 50 day moving average is $59.69 and its 200-day moving average is $49.35.

Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same quarter last year, the firm earned $0.14 EPS. Cognex’s revenue for the quarter was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, sell-side analysts predict that Cognex Corporation will post 1.41 EPS for the current year.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were issued a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 21st. Cognex’s dividend payout ratio (DPR) is presently 40.48%.

Analyst Ratings Changes

Several brokerages have commented on CGNX. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $80.00 price target (up from $70.00) on shares of Cognex in a research report on Monday, May 11th. TD Cowen reaffirmed a “buy” rating on shares of Cognex in a research report on Tuesday, February 17th. Barclays reaffirmed an “overweight” rating and issued a $75.00 price target (up from $64.00) on shares of Cognex in a research report on Monday, May 11th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $75.00 price target on shares of Cognex in a research report on Thursday, May 7th. Finally, JPMorgan Chase & Co. raised Cognex from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $65.00 to $75.00 in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $70.43.

Read Our Latest Stock Report on CGNX

Insider Transactions at Cognex

In other news, VP Darren Marc Long sold 20,252 shares of Cognex stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the sale, the vice president owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. This trade represents a 83.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Mark Fennell sold 64,873 shares of Cognex stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the sale, the insider directly owned 11,263 shares in the company, valued at $755,184.15. The trade was a 85.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 224,847 shares of company stock valued at $14,975,098. 1.70% of the stock is owned by corporate insiders.

About Cognex

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.